Literature DB >> 32303484

Lemierre's syndrome: A forgotten and re-emerging infection.

Wen-Sen Lee1, Shio-Shin Jean2, Fu-Lun Chen1, Szu-Min Hsieh3, Po-Ren Hsueh4.   

Abstract

Lemierre's syndrome, also known as post-anginal septicemia or necrobacillosis, is characterized by bacteremia, internal jugular vein thrombophlebitis, and metastatic septic emboli secondary to acute pharyngeal infections. Modern physicians have "forgotten" this disease. The most common causative agent of Lemierre's syndrome is Fusobacterium necrophorum, followed by Fusobacterium nucleatum and anaerobic bacteria such as streptococci, staphylococci, and Klebsiella pneumoniae. The causative focus mostly originated from pharyngitis or tonsillitis, accounting for over 85% of the cases of Lemierre's syndrome. Pneumonia or pleural empyema is the most common metastatic infection in Lemierre's syndrome. Antimicrobial therapy should be prescribed for 3-6 weeks. The treatment regimens include metronidazole and β-lactam antibiotics. In recent years, the antibiotic stewardship program has resulted in decreased antibiotic prescription for upper respiratory tract infections. The incidence of Lemierre's syndrome has increased over the past decade. F. necrophorum is an underestimated cause of acute pharyngitis or tonsillitis. A high index of suspicion is required for the differential diagnosis of acute tonsillopharyngitis with persistent neck pain and septic syndrome.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Bacteremia; Lemierre's syndrome; Septic emboli; Thrombophlebitis

Mesh:

Substances:

Year:  2020        PMID: 32303484     DOI: 10.1016/j.jmii.2020.03.027

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  8 in total

1.  Postoperative Lemierre's syndrome: a previously unreported complication of transoral surgery. Illustrative case.

Authors:  Giuseppe Mariniello; Sergio Corvino; Giuseppe Teodonno; Serena Pagano; Francesco Maiuri
Journal:  J Neurosurg Case Lessons       Date:  2021-04-26

2.  Lemierre Syndrome Due to Dialister pneumosintes: A Case Report.

Authors:  Jun Hirai; Tessei Kuruma; Daisuke Sakanashi; Yuji Kuge; Takaaki Kishino; Yuuichi Shibata; Nobuhiro Asai; Mao Hagihara; Hiroshige Mikamo
Journal:  Infect Drug Resist       Date:  2022-05-31       Impact factor: 4.177

3.  An Unusual Etiology of Lemierre-Like Syndrome: Preseptal Cellulitis due to Methicillin-Resistant Staphylococcus aureus.

Authors:  Noah Newman; Amlak Bantikassegn; Thomas G West; James E Peacock
Journal:  Open Forum Infect Dis       Date:  2022-04-18       Impact factor: 4.423

4.  Factors Affecting Patients with Concurrent Deep Neck Infection and Lemierre's Syndrome.

Authors:  Shih-Lung Chen; Shy-Chyi Chin; Yu-Chien Wang; Chia-Ying Ho
Journal:  Diagnostics (Basel)       Date:  2022-04-08

5.  Case report of atypical Lemierre's Syndrome associated with Fusobacterium nucleatum infection without internal or external jugular venous thrombophlebitis.

Authors:  Haidang D Nguyen; Patricia N Whitley-Williams; Lakshmi P Uppaluri; Jay Sangani; Mitchell L Simon; Aisha S Baig
Journal:  Respir Med Case Rep       Date:  2022-04-18

6.  Increasing Fusobacterium infections with Fusobacterium varium, an emerging pathogen.

Authors:  Se Ju Lee; Yae Jee Baek; Jin Nam Kim; Ki Hyun Lee; Eun Hwa Lee; Joon Sup Yeom; Jun Yong Choi; Nam Su Ku; Jin Young Ahn; Jung Ho Kim; Su Jin Jeong
Journal:  PLoS One       Date:  2022-04-14       Impact factor: 3.752

7.  Late presentation of 'Lemierre's syndrome': how a delay in seeking healthcare and reduced access to routine services resulted in widely disseminated Fusobacterium necrophorum infection during the global COVID-19 pandemic.

Authors:  Fergal Howley; Laura O'Doherty; Niall McEniff; Ruth O'Riordan
Journal:  BMJ Case Rep       Date:  2020-10-10

8.  Early Diagnosis and Antibiotic Treatment Combined with Multicomponent Hemodynamic Support for Addressing a Severe Case of Lemierre's Syndrome.

Authors:  Andreaserena Recchia; Marco Cascella; Sabrina Altamura; Felice Borrelli; Nazario De Nittis; Elisabetta Dibenedetto; Maria Labonia; Giovanna Pavone; Alfredo Del Gaudio
Journal:  Antibiotics (Basel)       Date:  2021-12-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.